Dr. Olga Paley, Director of Bioprocess Development at Takeda, will discuss “Advancing Takeda’s Bioprocessing Platforms in Support of Clinical and Commercial Drug Supply” about the Chemistry, ...

The CMC package required to effectively demonstrate safety and efficacy of increasingly complex gene therapy products to regulators needs to keep pace. The 6th Gene Therapy Analytical Development ...

minimise waste and lower costs. In addition, AI could simplify compliance by making sure that manufacturing processes meet regulatory guidelines. Cell therapy development generates massive amounts ...

Cellistic, a pioneer in iPSC-based off-the-shelf cell therapy development ... leap forward in cell line development, effectively reducing both timelines and costs. Leveraging Cellistic's extensive ...